Renkai Li

Renkai Li

Auto-generated profile, based on publicly available information

Renkai Li

Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region of China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2023 in Phytomedicine
Verified
Journal Article
Closed access
YCYanfen Cheng
Yanfen Cheng
XZXuemei Zhong
Xuemei Zhong
XNXin Nie
Xin Nie
HGHuan Gu
Huan Gu
XWXiaoping Wu
Xiaoping Wu
JLJingjing Li
Jingjing Li

28 March 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
RLRenkai Li
Renkai Li
CZChengwen ZHENG
Chengwen ZHENG
PSPolly Ho-Ting Shiu
Polly Ho-Ting Shiu
PRPanthakarn Rangsinth
Panthakarn Rangsinth
WWWen Wang
Wen Wang
GLGeorge LEUNG
George LEUNG
Despite various therapeutic approaches, colorectal cancer is among the most fatal diseases globally. Hence, developing novel and more effective methods for colorectal cancer treatment is essential. Recently, reactive oxygen species (ROS)/JNK signaling pathway has been proposed as the potential target for the anticancer drug discovery. The present study investigated the anticancer effects of the bioactive xanthone garcinone E (GAR E) in mangosteen and explored its underlying mechanism of action. HT-29 and Caco-2 cancer cells were used as in vitro models to study the anticancer effect of GAR E. The findings demonstrated that GAR E inhibited colony formation and wound healing, whereas triggered the production of ROS, which induced mitochondrial dysfunction and apoptosis, causing cell cycle arrest at the Sub G1 phase. Additionally, GAR E treatment elevated the ratio of Bax/Bcl-2 and activated PARP, caspases 3 and 9, and JNK1/2. These GAR E-induced cytotoxic activities and expression of signaling proteins were reversed by the antioxidant N-acetyl-L-cysteine and JNK inhibitor SP600125, indicating the involvement of ROS/JNK signaling pathways. In vivo experiments using an HT-29 xenograft nude mouse model also demonstrated the antitumor effect of GAR E. In conclusion, our findings showed that GAR E might be potentially effective in treating colorectal cancer and provided insights into the development of xanthones as novel chemotherapeutic agents.

27 March 2019 in Phytochemical Analysis
Verified
Journal Article
Closed access
PDF file
ICIssac Chi‐Chung Cheng
Issac Chi‐Chung Cheng
RLRen‐Kai Li
Ren‐Kai Li
GLGeorge LEUNG
George LEUNG
SLSong‐Lin Li
Song‐Lin Li
MKMing Kong
Ming Kong
WMWei Meng
Wei Meng

1 August 2021 in European Journal of Pharmacology
Verified
Journal Article
Closed access
SWSze Wan Emily Wong
Sze Wan Emily Wong
RLRachel Wai-Sum Li
Rachel Wai-Sum Li
JLJingjing Li
Jingjing Li
RLRenkai Li
Renkai Li
SSSai-Wang Seto
Sai-Wang Seto
GLGeorge LEUNG
George LEUNG

13 January 2023 in Bangladesh Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
PSPolly Ho-Ting Shiu
Polly Ho-Ting Shiu
CZChengwen ZHENG
Chengwen ZHENG
PRPanthakarn Rangsinth
Panthakarn Rangsinth
WWWen Wang
Wen Wang
JLJingjing Li
Jingjing Li
GLGeorge Pak-Heng Leung
George Pak-Heng Leung
The objectives of the present study were to evaluate the antioxidant and anti-inflammatory effects of gallic acid, a naturally occurring triphenolic compound, on HaCaT keratinocytes and study its mechanisms of action. The results showed that gallic acid at concentrations lower than 30 µM was non-toxic to HaCaT cells, reduced the intracellular level of reactive oxygen species, and suppressed the release of chemokines interleukin-8 and monocyte chemoattractant protein-1 in tumor necrosis factor-α- and interferon-γ-stimulated HaCaT keratinocytes. In addition, gallic acid reduced the total protein expression of NF-κB and inhibited the phosphorylation of ERK1/2, p38 MAPK, and Akt in stimulated HaCaT keratinocytes. In conclusion, our study revealed that gallic acid exhibited antioxidant and anti-inflammatory effects on keratinocytes, probably through the inhibition of MAPK-, NF-κB-, and Akt-dependent signaling pathways.